[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
June 24, 1998

Cancer Experts Offer Healthy Dose of Skepticism Toward Hype Over Antiangiogenesis Agents

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;279(24):1936-1937. doi:10.1001/jama.279.24.1936-JMN0624-2-1

FOR 2 WEEKS leading up to the annual meeting of the American Society of Clinical Oncology (ASCO) last month, the media hoopla was intense surrounding 2 antiangiogenesis agents—compounds that inhibit the formation of new blood vessels, such as those that supply a cancerous tumor—that have shown potent anticancer activity in mice.

The frenzy of coverage in the nation's major newspapers, national news magazines, television, radio, and on the Internet led thousands of patients to besiege their physicians to help them obtain what some perceived as a cure for cancer.

First Page Preview View Large
First page PDF preview
First page PDF preview
×